PremiumThe FlyBiotech Alert: Searches spiking for these stocks today Elastic, Monster, Caesars, Catalyst, Corbus: Stock Shake-Up! Catalyst Pharmaceuticals price target raised to $32 from $28 at Baird PremiumThe FlyCatalyst Pharmaceuticals reports Q4 EPS 70c, consensus 55c Catalyst Pharmaceuticals sees FY25 revenue $545M-$565M, consensus $558.08M Catalyst Pharmaceutical Partners (CPRX) Q4 Earnings Cheat Sheet PremiumThe FlyCatalyst announces sub-licensee pharma launches FIRDAPSE in Japan Catalyst Pharma Highlights Growth in Rare Diseases Sector Catalyst Pharmaceuticals price target raised to $31 from $29 at Oppenheimer 
